RANK | DEVELOPED COUNTRIES* | DEVELOPING COUNTRIES † | ||||
---|---|---|---|---|---|---|
CONDITION | RANK SCORE‡ (MAXIMUM SCORE OF 20) | NO. OF ANALYSES THAT INCLUDED THE CONDITION (OUT OF 5) | CONDITION | RANK SCORE‡ (MAXIMUM SCORE OF 20) | NO. OF ANALYSES THAT INCLUDED THE CONDITION (OUT OF 4) | |
1 | Hypertension | 17.4 | 5 | Upper respiratory tract infection, unspecified | 18.5 | 4 |
2 | Upper respiratory tract infection, unspecified | 15.2 | 4 | Hypertension | 14.5 | 3 |
3 | Depression or anxiety | 12.0 | 5 | Pneumonia | 11.5 | 4 |
4 | Back pain | 12.0 | 4 | Tuberculosis | 10.0 | 3 |
5 | Routine health maintenance | 11.6 | 3 | Parasites | 9.0 | 2 |
6 | Arthritis (not back) | 10.0 | 4 | Anemia | 8.3 | 2 |
7 | Dermatitis | 8.6 | 4 | Diabetes | 8.3 | 2 |
8 | Acute otitis media | 8.6 | 4 | Arthritis (not back) | 6.5 | 2 |
9 | Diabetes | 8.6 | 3 | Bronchitis or bronchiolitis | 6.3 | 2 |
10 | Cough | 7.0 | 2 | Epilepsy | 6.0 | 2 |
11 | Medication | 5.8 | 2 | Urinary tract infection | 5.5 | 2 |
12 | Urinary tract infection | 5.4 | 3 | Tonsillitis | 5.5 | 2 |
RFV—reason for visit.
↵* Studies in this analysis included the following: Binns et al,11 2007; Britt et al,12 2015; Fleming et al,19 2005; National Center for Health Statistics,25 2017; and Wändell et al,13 2013.
↵† Studies in this analysis included the following: Brueton et al,18 2010; Mash et al,21 2012; Mohan and Nagavi,23 2003; and Salvi et al,29 2015.
↵‡ Higher scores mean the condition was reported as a more common RFV in more studies.